Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome
- PMID: 9708505
Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome
Abstract
Involvement of the brain is one of the most important complications of Sjögren's syndrome (SS). However, diagnosis of brain involvement in SS patients is difficult due to the lack of effective imaging methods. In this study, we compared two updated brain imaging modalities, 18F-2-fluoro-2-deoxy-D-glucose (FDG) PET and 99mTc-hexamethyl propyleneamine oxime (HMPAO) SPECT, in SS patients with neuropsychiatric manifestations, to detect glucose metabolism of the brain and regional cerebral blood flow.
Methods: Sixteen primary female SS patients with normal brain MRI findings were enrolled in this study.
Results: Technetium-99m-HMPAO SPECT findings were abnormal in 13 (81%) patients. Parietal and temporal lobes were the most common areas of brain involvement. Fluorine-18-FDG PET findings were abnormal in 3 (19%) patients. Temporal lobes were the most common areas of brain involvement.
Conclusion: We conclude that brain HMPAO SPECT has better correlation with clinical manifestations than brain FDG PET or CT/MRI.
Similar articles
-
Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome.J Nucl Med. 1998 May;39(5):773-7. J Nucl Med. 1998. PMID: 9591573
-
Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.Arthritis Rheum. 1999 Jan;42(1):61-8. doi: 10.1002/1529-0131(199901)42:1<61::AID-ANR8>3.0.CO;2-9. Arthritis Rheum. 1999. PMID: 9920015
-
[Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].Rev Esp Med Nucl. 2011 Sep-Oct;30(5):301-6. doi: 10.1016/j.remn.2011.03.010. Epub 2011 Jun 2. Rev Esp Med Nucl. 2011. PMID: 21640440 Spanish.
-
[Clinical positron emission tomography: brain imaging].Orv Hetil. 2002 May 26;143(21 Suppl 3):1294-7. Orv Hetil. 2002. PMID: 12077920 Review. Hungarian.
-
Imaging of cerebral blood flow and metabolism.Curr Opin Anaesthesiol. 2006 Oct;19(5):473-80. doi: 10.1097/01.aco.0000245270.90377.00. Curr Opin Anaesthesiol. 2006. PMID: 16960477 Review.
Cited by
-
CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.CNS Drugs. 2001;15(8):597-607. doi: 10.2165/00023210-200115080-00003. CNS Drugs. 2001. PMID: 11524032 Review.
-
A plea for the elective inclusion of the brain in routine whole-body FDG PET.Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):251-6. doi: 10.1007/s00259-004-1729-0. Eur J Nucl Med Mol Imaging. 2005. PMID: 15692807 No abstract available.
-
Central Nervous System Involvement in Primary Sjögren's Syndrome: Narrative Review of MRI Findings.Diagnostics (Basel). 2022 Dec 21;13(1):14. doi: 10.3390/diagnostics13010014. Diagnostics (Basel). 2022. PMID: 36611306 Free PMC article. Review.
-
White matter water diffusion changes in primary Sjögren syndrome.AJNR Am J Neuroradiol. 2014 Apr;35(4):680-5. doi: 10.3174/ajnr.A3756. Epub 2013 Nov 1. AJNR Am J Neuroradiol. 2014. PMID: 24184520 Free PMC article. Clinical Trial.
-
Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report.Rheumatol Int. 2003 Nov;23(6):301-4. doi: 10.1007/s00296-003-0314-3. Epub 2003 Apr 9. Rheumatol Int. 2003. PMID: 12684837 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
